Citations Report

Clinical Investigation : Citations & Metrics Report

Articles published in Clinical Investigation have been cited by esteemed scholars and scientists all around the world.

Clinical Investigation has got h-index 28, which means every article in Clinical Investigation has got 28 average citations.

Following are the list of articles that have cited the articles published in Clinical Investigation.

• Sam, R., Ryan, E., Daykin, E., & Sidransky, E. (2021). Current and emerging pharmacotherapy for Gaucher disease in pediatric populations. Expert Opinion on Pharmacotherapy, 1-15. View at Publisher | View at Google Scholar | View at Indexing
• Dinur, Tama, et al. "Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations." International Journal of Molecular Sciences 22.14 (2021): 7699. View at Publisher | View at Google Scholar | View at Indexing
• Berg, D. (2021). Parkinson’s disease patients with heterozygous GBA-mutation: longitudinal phenotyping of motor and non-motor symptoms–more rapid progression compared to Parkinson’s disease patients without GBA-mutation (Doctoral dissertation, Universität Tübingen). View at Publisher | View at Google Scholar | View at Indexing
• Wagner, Elisamar Santos Marin. "Purificação da enzima glucocerebrosidase humana produzida no leite do primeiro clone caprino transgênico da América Latina." (2016). View at Publisher | View at Google Scholar | View at Indexing
• Ribeiro, M. L. F. S., & Reis, S. (2016). Caraterização das fases iniciais da retinopatia diabética. Diagnóstico precoce e biomarcadores da atividade da retinopatia (Doctoral dissertation). View at Publisher | View at Google Scholar | View at Indexing
• AIR, EOFGUMCO, and SALIVA SWALLOWING SWALLOWING. "Artigo Original/Original Article." View at Publisher | View at Google Scholar | View at Indexing
• Lim, K. R. Q., Maruyama, R., & Yokota, T. (2017). Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug design, development and therapy, 11, 533. View at Publisher | View at Google Scholar | View at Indexing
• Scholz, Roland W., and Friedrich W. Wellmer. "Endangering the integrity of science by misusing unvalidated models and untested assumptions as facts: General considerations and the mineral and phosphorus scarcity fallacy." Sustainability science (2021): 1-18. View at Publisher | View at Google Scholar | View at Indexing
• Elmar, Kotter, et al. "ESR white paper: blockchain and medical imaging." Insights into Imaging 12.1 (2021). View at Publisher | View at Google Scholar | View at Indexing
• Faria, R. (2018). What Is Research Misconduct?. In Research Misconduct as White-Collar Crime (pp. 39-70). Palgrave Macmillan, Cham. View at Publisher | View at Google Scholar | View at Indexing
• Bradshaw, M. S., & Payne, S. H. (2019). Detecting fabrication in large-scale molecular omics data. bioRxiv, 757070. View at Publisher | View at Google Scholar | View at Indexing
• Dwivedi, Gayatri, and Manorama Tripathi. "Stemming misconduct in higher education and research." (2017). View at Publisher | View at Google Scholar | View at Indexing
• Hurley, C. (2018). Implementation of risk based monitoring into academic led clinical trials in Ireland (Doctoral dissertation, University College Cork). View at Publisher | View at Google Scholar | View at Indexing
• Wong, Daniel R., Sanchita Bhattacharya, and Atul J. Butte. "Prototype of running clinical trials in an untrustworthy environment using blockchain." Nature communications 10.1 (2019): 1-8. View at Publisher | View at Google Scholar | View at Indexing
• Atal, I., Porcher, R., Boutron, I., & Ravaud, P. (2019). The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses. Journal of clinical epidemiology, 111, 32-40. View at Publisher | View at Google Scholar | View at Indexing
• Gewandter, Jennifer S., et al. "Improving study conduct and data quality in clinical trials of chronic pain treatments: IMMPACT recommendations." The journal of pain 21.9-10 (2020): 931-942. View at Publisher | View at Google Scholar | View at Indexing
• Galor, A., Moein, H. R., Lee, C., Rodriguez, A., Felix, E. R., Sarantopoulos, K. D., & Levitt, R. C. (2018). Neuropathic pain and dry eye. The ocular surface, 16(1), 31-44. View at Publisher | View at Google Scholar | View at Indexing
• Grimaudo, M. A., Pescina, S., Padula, C., Santi, P., Concheiro, A., Alvarez-Lorenzo, C., & Nicoli, S. (2018). Poloxamer 407/TPGS mixed micelles as promising carriers for cyclosporine ocular delivery. Molecular pharmaceutics, 15(2), 571-584. View at Publisher | View at Google Scholar | View at Indexing
• Garrigue, J. S., Amrane, M., Faure, M. O., Holopainen, J. M., & Tong, L. (2017). Relevance of lipid-based products in the management of dry eye disease. Journal of Ocular Pharmacology and Therapeutics, 33(9), 647-661. View at Publisher | View at Google Scholar | View at Indexing
• Lalu, L., Tambe, V., Pradhan, D., Nayak, K., Bagchi, S., Maheshwari, R., ... & Tekade, R. K. (2017). Novel nanosystems for the treatment of ocular inflammation: Current paradigms and future research directions. Journal of Controlled Release, 268, 19-39. View at Publisher | View at Google Scholar | View at Indexing
• Abhirup Mandal, Vrinda Gote, Dhananjay Pal, Abayomi Ogundele & Ashim K. Mitra. " Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease". View at Publisher | View at Google Scholar | View at Indexing
• Alvarez-Trabado, Jesus, Yolanda Diebold, and Alejandro Sanchez. "Designing lipid nanoparticles for topical ocular drug delivery." International journal of pharmaceutics 532.1 (2017): 204-217. View at Publisher | View at Google Scholar | View at Indexing
• Meng, T., Kulkarni, V., Simmers, R., Brar, V., & Xu, Q. (2019). Therapeutic implications of nanomedicine for ocular drug delivery. Drug discovery today, 24(8), 1524-1538. View at Publisher | View at Google Scholar | View at Indexing
• Liu, R., Wang, S., Fang, S., Wang, J., Chen, J., Huang, X., ... & Liu, C. (2016). Liquid crystalline nanoparticles as an ophthalmic delivery system for tetrandrine: development, characterization, and in vitro and in vivo evaluation. Nanoscale research letters, 11(1), 1-12. View at Publisher | View at Google Scholar | View at Indexing
• Dawes, P., Cruickshanks, K. J., Marsden, A., Moore, D. R., & Munro, K. J. (2020). Relationship between diet, tinnitus, and hearing difficulties. Ear and hearing, 41(2), 289. View at Publisher | View at Google Scholar | View at Indexing
• Lavigne, M., Birken, C. S., Maguire, J. L., Straus, S., & Laupacis, A. (2017). Priority setting in paediatric preventive care research. Archives of disease in childhood, 102(8), 748-753. View at Publisher | View at Google Scholar | View at Indexing
• Aazh, H., & Moore, B. C. (2018). Proportion and characteristics of patients who were offered, enrolled in and completed audiologist-delivered cognitive behavioural therapy for tinnitus and hyperacusis rehabilitation in a specialist UK clinic. International journal of audiology, 57(6), 415-425. View at Publisher | View at Google Scholar | View at Indexing
• Christie, J., Gray, T. A., Dumville, J. C., & Cullum, N. A. (2018). Do systematic reviews address community healthcare professionals’ wound care uncertainties? Results from evidence mapping in wound care. PLoS One, 13(1), e0190045. View at Publisher | View at Google Scholar | View at Indexing
• Fackrell, Kathryn, Linda Stratmann, Veronica Kennedy, Carol MacDonald, Hilary Hodgson, Nic Wray, Carolyn Farrell et al. "Identifying and prioritising unanswered research questions for people with hyperacusis: James Lind Alliance Hyperacusis Priority Setting Partnership." BMJ open 9, no. 11 (2019): e032178. View at Publisher | View at Google Scholar | View at Indexing
• Hammill, T. L. (2017). An evidence-base and implementation framework for promoting best practices in pharmaceutical interventions for hearing loss (PIHL) research (Doctoral dissertation). View at Publisher | View at Google Scholar | View at Indexing
• Mills, Christopher C., E. A. Kolb, and Valerie B. Sampson. "Recent advances of cell-cycle inhibitor therapies for pediatric cancer." Cancer research 77.23 (2017): 6489-6498. View at Publisher | View at Google Scholar | View at Indexing
• Bragge, P., Synnot, A., Maas, A. I., Menon, D. K., Cooper, D. J., Rosenfeld, J. V., & Gruen, R. L. (2016). A state-of-the-science overview of randomized controlled trials evaluating acute management of moderate-to-severe traumatic brain injury. Journal of neurotrauma, 33(16), 1461-1478. View at Publisher | View at Google Scholar | View at Indexing
• Xiong, Y., Zhang, Y., Mahmood, A., & Chopp, M. (2015). Investigational agents for treatment of traumatic brain injury. Expert opinion on investigational drugs, 24(6), 743-760. View at Publisher | View at Google Scholar | View at Indexing
• View at Publisher | View at Google Scholar | View at Indexing
• Nunn, A., Bath, P. M., & Gray, L. J. (2016). Analysis of the modified Rankin scale in randomised controlled trials of acute ischaemic stroke: a systematic review. Stroke research and treatment, 2016. View at Publisher | View at Google Scholar | View at Indexing
• Gronbeck, K. R., Rodrigues, C. M., Mahmoudi, J., Bershad, E. M., Ling, G., Bachour, S. P., & Divani, A. A. (2016). Application of tauroursodeoxycholic acid for treatment of neurological and non-neurological diseases: is there a potential for treating traumatic brain injury?. Neurocritical care, 25(1), 153-166. View at Publisher | View at Google Scholar | View at Indexing
• van Essen, Thomas A., Godard CW de Ruiter, Kuan H. Kho, and Wilco C. Peul. "Neurosurgical treatment variation of traumatic brain injury: evaluation of acute subdural hematoma management in Belgium and The Netherlands." Journal of neurotrauma 34, no. 4 (2017): 881-889. View at Publisher | View at Google Scholar | View at Indexing
• Vázquez-Rosa, E., Watson, M. R., Sahn, J. J., Hodges, T. R., Schroeder, R. E., Cintrón-Pérez, C. J., ... & Pieper, A. A. (2018). Neuroprotective efficacy of a sigma 2 receptor/TMEM97 modulator (DKR-1677) after traumatic brain injury. ACS chemical neuroscience, 10(3), 1595-1602. View at Publisher | View at Google Scholar | View at Indexing
• Paul, Friedemann. "Hope for a rare disease: eculizumab in neuromyelitis optica." The Lancet Neurology 12.6 (2013): 529-531. View at Publisher | View at Google Scholar | View at Indexing
• Bodien, Y. G., McCrea, M., Dikmen, S., Temkin, N., Boase, K., Joan, M., ... & TRACK-TBI Investigators. (2018). Optimizing outcome assessment in multicenter TBI trials: perspectives from TRACK TBI and the TBI Endpoints Development Initiative. The Journal of head trauma rehabilitation, 33(3), 147. View at Publisher | View at Google Scholar | View at Indexing
• Rodriguez-Grande, Beatriz, et al. "Early to long-term alterations of CNS barriers after traumatic brain injury: considerations for drug development." The AAPS journal 19.6 (2017): 1615-1625. View at Publisher | View at Google Scholar | View at Indexing
• Hutchison, James S., and Anne-Marie Guerguerian. "Cooling of children with severe traumatic brain injury." The Lancet Neurology 12.6 (2013): 527-529. View at Publisher | View at Google Scholar | View at Indexing
• Mondello, Stefania, et al. "Circulating brain injury exosomal proteins following moderate-to-severe traumatic brain injury: temporal profile, outcome prediction and therapy implications." Cells 9.4 (2020): 977. View at Publisher | View at Google Scholar | View at Indexing
• Markovic, Gabriela, Marie-Louise Schult, and Aniko Bartfai. "The effect of sampling bias on generalizability in intervention trials after brain injury." Brain injury 31.1 (2017): 9-15. View at Publisher | View at Google Scholar | View at Indexing
• Gaastra, B., Ren, D., Alexander, S., Bennett, E. R., Bielawski, D. M., Blackburn, S. L., ... & Galea, I. (2019). Haptoglobin genotype and aneurysmal subarachnoid hemorrhage: individual patient data analysis. Neurology, 92(18), e2150-e2164. View at Publisher | View at Google Scholar | View at Indexing
• ASH-CT prognostic model for older adults with traumatic brain injury: a population-based observational cohort study. The Journal of head trauma rehabilitation, 31(5), E8-E14.trauma rehabilitation, 31(5), E8-E14. View at Publisher | View at Google Scholar | View at Indexing
• Markovic, G. (2017). Acquired brain injury and evaluation of intensive training of attention in early neurorehabilitation: statistical evaluation and qualitative perspectives. View at Publisher | View at Google Scholar | View at Indexing
• Chellappan, D. K., Chellian, J., Ng, Z. Y., Sim, Y. J., Theng, C. W., Ling, J., ... & Gupta, G. (2017). The role of pazopanib on tumour angiogenesis and in the management of cancers: A review. Biomedicine & Pharmacotherapy, 96, 768-781. View at Publisher | View at Google Scholar | View at Indexing
• Hu, Y., Ren, H., Yang, L., Jin, C., & Wei, Y. (2020). Effect of molecular targeted therapy combined with radio-therapy on the expression and prognostic value of COX-2 and VEGF in bone metastasis of lung cancer. Journal of BU ON.: official journal of the Balkan Union of Oncology, 25(2), 811-820. View at Publisher | View at Google Scholar | View at Indexing
• Hakim, S. A. (2016). Estrogen receptor β, a potential prognostic and therapeutic marker in urothelial carcinoma, is altered by associating schistosomiasis. Egyptian Journal of Pathology, 36(2), 260-266. View at Publisher | View at Google Scholar | View at Indexing